News

Natural Alternatives International, Inc. Announces 2021 Q4 and YTD Results

  • CARLSBAD, Calif., Sept. 20, 2021 /PRNewswire/ -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements, today announced net income of $3.0 million, or $0.47 per diluted share, on net sales of $44.4 million for the fourth quarter of fiscal year 2021 compared to net income of $1.8 million, or $0.27 per diluted share, in the fourth quarter of the prior fiscal year.
    09/20/2021

Natural Alternatives International, Inc. Announces Acquisition of Manufacturing and Warehouse Facility

  • CARLSBAD, Calif., Aug. 24, 2021 /PRNewswire/ -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements, today announced the purchase of a 54,154 ft2 manufacturing and warehouse facility in Carlsbad, CA in a transaction that closed on August 20, 2021.
    08/24/2021
Profitability
Dividends
Income Statement
Balance Sheet
Cash Flow Statement
Symbol Frequently Asked Questions

Natural Alternatives International, Inc. (NAII) can buy. Click on Rating Page for detail.

The price of Natural Alternatives International, Inc. (NAII) is 9.27 and it was updated on 2022-10-06 13:00:24.

Currently Natural Alternatives International, Inc. (NAII) is in overvalued.

News
    
News

Natural Alternatives International, Inc. Announces New and Expanded Credit Facility with Wells Fargo Bank

  • CARLSBAD, Calif., May 27, 2021 /PRNewswire/ -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements, today announced the execution of a new and expanded credit facility with Wells Fargo Bank, NA ("Wells Fargo").
    Thu, May. 27, 2021

Natural Alternatives International, Inc. Announces a $3 Million Increase in its Stock Repurchase Plan

  • CARLSBAD, Calif., March 18, 2021 /PRNewswire/ -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements, today announced its Board of Directors authorized a $3.0 million increase to its stock repurchase plan bringing the total plan authorized repurchase amount to $15.0 million.
    Thu, Mar. 18, 2021

Natural Alternatives International, Inc. Announces 2021 Q1 Results

  • CARLSBAD, Calif,, Nov. 10, 2020 /PRNewswire/ -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements, today announced net income of $2.3 million, or $0.35 per diluted share, on net sales of...
    Tue, Nov. 10, 2020

Jeff Davanon Joins Carnosyn® Brands

  • Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), the company behind SR CarnoSyn®, a patented, sustained-release beta-alanine, announced Jeff DaVanon has joined CarnoSyn® Brands as Health & Wellness Business Development Manager.
    Wed, Aug. 19, 2020

Natural Alternatives International, Inc. (NASDAQ:NAII) Short Interest Down 7.1% in June

  • Natural Alternatives International, Inc. (NASDAQ:NAII) saw a large decline in short interest during the month of June. As of June 15th, there was short interest totalling 1,300 shares, a decline of 7.1% from the May 31st total of 1,400 shares. Based on an average daily trading volume, of 7,000 shares, the short-interest ratio is currently […]
    Mon, Jun. 22, 2020
SEC Filings
SEC Filings
Press Releases
StockPrice Release
More Headlines
News

Natural Alternatives International, Inc. (NASDAQ:NAII) Sees Significant Drop in Short Interest

  • Natural Alternatives International, Inc. (NASDAQ:NAII) saw a large decrease in short interest in May. As of May 29th, there was short interest totalling 1,300 shares, a decrease of 7.1% from the May 14th total of 1,400 shares. Approximately 0.0% of the shares of the stock are sold short. Based on an average daily volume of […]
  • 06/14/2020

Natuzzi S.p.A.: Unaudited Consolidated Results for the Fourth Quarter and Full Year 2019 | MarketScreener

  • 05/23/2020

Natural Alternatives Q3 EPS $(0.610) Down From $0.270 YoY, Sales $25.482M Down From $35.455M YoY

  • 05/14/2020

Natural Alternatives International, Inc. Announces 2020 Q3 and YTD Results

  • Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements, today announced a net loss of $4.0 million, or $0.61 per diluted share, for the quarter ended March 31, 2020.
  • 05/14/2020

Analysis on New Product Launches in Covid-19 Related Markets-Global Animal Wound Care Market 2020-2024 | Evolving Opportunities with 3M Co. and B. Braun Melsungen AG | Technavio

  • The animal wound care market size has the potential to grow by USD 661.63 million during 2020-2024
  • 05/05/2020

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Natural Alternatives International, Inc. - NAII

  • NEW YORK, NY / ACCESSWIRE / April 7, 2020 / Levi & Korsinsky announces it has commenced an investigation of Natural Alternatives International, Inc. (NASDAQ:NAII) concerning possible breaches of fiduciary ...
  • 04/07/2020

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Natural Alternatives International, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors

  • Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of Natural Alternatives International, Inc. (NASDAQ: NAII).
  • 04/07/2020

INVESTOR ALERT: Fields Kupka & Shukurov LLP Is Investigating Natural Alternatives International, Inc. for Potential Breach of Fiduciary Duty Claims

  • NEW YORK, April 06, 2020 -- Fields Kupka & Shukurov LLP is investigating potential breach of fiduciary duty claims involving the board of directors of Natural Alternatives.
  • 04/06/2020

INVESTOR ALERT: Fields Kupka & Shukurov LLP Is Investigating Natural Alternatives ...

  • 04/06/2020

Our Take On Natural Alternatives International, Inc.'s (NASDAQ:NAII) CEO Salary

  • Mark LeDoux became the CEO of Natural Alternatives International, Inc. (NASDAQ:NAII) in 1986. First, this article will...
  • 03/20/2020

Stocks That Hit 52-Week Lows On Friday

  • 03/20/2020

Natural Alternatives International, Inc. Earlier Announces Increase In Buyback By $1M To A Total Of $10M

  • 03/19/2020

Natural Alternatives International, Inc. Announces Increase in its Stock Repurchase Plan

  • Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements, today announced its Board of Directors authorized a $1.0 million increase to its stock repurchase plan bringing the total plan authorized repurchase amount to $10.0 million. Under the repurchase plan, NAI may, from time to time, purchase shares of its common stock, depending upon market conditions, in open market or privately negotiated transactions. Since December 31, 2019, we have purchased an additional 198,336 shares of our common stock under this plan bringing our total plan purchases to date to 1.2 million shares. At present there is $2.0 million remaining available for stock repurchases under the plan.
  • 03/19/2020

CarnoSyn® Brands Enters Third Year of Strategic Partnership with TEST Football Academy

  • CarnoSyn® Brands, a division of Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), and one of the world's leading sports performance ingredients, has partnered with TEST Football Academy for the third year in a row to fuel NFL hopefuls in their preparation for the combine and their respective collegiate pro days. Several new Team CarnoSyn® athletes made their mark at the 2020 NFL Scouting Combine.
  • 03/06/2020

Stocks That Hit 52-Week Lows On Friday

  • 02/28/2020

Stocks That Hit 52-Week Lows On Wednesday

  • 02/12/2020

Natural Alternatives Q2 EPS $0.07 Down From $0.31 YoY, Sales $29.103M Down From $36.043M YoY

  • 02/11/2020

Natural Alternatives International, Inc. Announces 2020 Q2 and YTD Results

  • Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements, today announced net income of $476,000, or $0.07 per diluted share.
  • 02/11/2020

CarnoSyn® Brands Presenting Latest Health And Wellness Solutions During IHS Conference

  • Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), the company behind SR CarnoSyn®, a patented, sustained-release beta-alanine, will exhibit at the Integrative Healthcare Symposium (IHS) Annual Conference in New York, NY on February 20-22, 2020 at the New York Hilton Midtown. The CarnoSyn® Brands team will present the latest clinical research on their groundbreaking ingredient solution for healthy aging and everyday wellness during a luncheon session on Friday, February 21st.
  • 01/29/2020

Should You Worry About Natural Alternatives International, Inc.’s (NASDAQ:NAII) ROCE?

  • Today we'll evaluate Natural Alternatives International, Inc. (NASDAQ:NAII) to determine whether it could have...
  • 01/20/2020

Natural Alternatives International Adds $2M To Buyback

  • 01/13/2020

Natural Alternatives International increases stock repurchase program by $2M NAII

  • Natural Alternatives International increases stock repurchase program by $2M NAII
  • 01/13/2020

Stocks That Hit 52-Week Lows On Friday

  • 11/29/2019

Stocks That Hit 52-Week Lows On Friday

  • 11/15/2019

Natural Alternatives Q1 EPS $0.01 Down From $0.37 YoY, Sales $29.2M Down From $36.532M YoY

  • 11/14/2019

Natural Alternatives International, Inc. Announces 2020 Q1 Results

  • CARLSBAD, Calif. , Nov. 14, 2019 /PRNewswire/ -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements, ...
  • 11/14/2019

Natural Alternatives reports Q1 results

  • 11/14/2019

CarnoSyn® Brands Showcasing Groundbreaking Health And Wellness Solutions At AMMG Conference

  • TUCSON, Ariz. , Nov. 6, 2019 /PRNewswire/ -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), the company behind SR CarnoSyn ® , a patented, sustained-release version of CarnoSyn ...
  • 11/06/2019

Do You Like Natural Alternatives International, Inc. (NASDAQ:NAII) At This P/E Ratio?

  • This article is written for those who want to get better at using price to earnings ratios (P/E ratios). We'll apply a...
  • 10/17/2019

CarnoSyn® Brands Showcasing Latest Innovations At SupplySide West

  • LAS VEGAS , Oct. 16, 2019 /PRNewswire/ -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), the company behind SR CarnoSyn®, a patented, sustained-release version of beta-alanine, ...
  • 10/16/2019

Stocks That Hit 52-Week Lows On Wednesday

  • 09/25/2019

Natural Alternatives International, Inc. Announces Fiscal Year 2019 and Q4 Results

  • - Fiscal Year 2019 Sales of $138.3 million - Fiscal Year 2019 Net Income of $6.5 million and $0.92 in Diluted EPS CARLSBAD, Calif. , Sept. 24, 2019 /PRNewswire/ -- Natural Alternatives International, Inc. ...
  • 09/24/2019

Natural Alternatives Q4 EPS $(0.03) Down From $0.38 YoY, Sales $30.26M Down From $39.213M YoY

  • 09/24/2019

The Natural Products Association Honors CarnoSyn® Beta-Alanine with the 2019 Novel Ingredient and Science Award

  • CARLSBAD, Calif., Sept. 17, 2019 /PRNewswire/ -- Natural Alternatives International, Inc. ("NAI") (NAII) today proudly announces its CarnoSyn® beta-alanine has received the coveted Novel Ingredient and Science Award from the Natural Products Association (NPA) at their annual conference, The Big Natural, in Washington, D.C., held September 11-12, 2019. The Novel Ingredient and Science Award is bestowed annually upon a person or company who has developed an innovative ingredient with far reaching applications, clinical disease utility, health benefit, or regulatory safety achievement, demonstrated through sound scientific research. The NPA recognizes NAI for its leadership in the industry, commitment to innovation, research and performance, and its perseverance to go above and beyond—achieving New Dietary Ingredient (NDI) status from the FDA for CarnoSyn® beta-alanine.
  • 09/17/2019

Can You Imagine How Natural Alternatives International's (NASDAQ:NAII) Shareholders Feel About The 81% Share Price Increase?

  • It hasn't been the best quarter for Natural Alternatives International, Inc. (NASDAQ:NAII) shareholders, since the...
  • 09/11/2019

Should Natural Alternatives International, Inc.’s (NASDAQ:NAII) Weak Investment Returns Worry You?

  • Today we'll evaluate Natural Alternatives International, Inc. (NASDAQ:NAII) to determine whether it could have...
  • 08/12/2019

What Kind Of Shareholder Appears On The Natural Alternatives International, Inc.'s (NASDAQ:NAII) Shareholder Register?

  • If you want to know who really controls Natural Alternatives International, Inc. (NASDAQ:NAII), then you'll have to...
  • 07/12/2019

Natural Alternatives Q3 EPS $0.27 Down From $0.3 YoY, Sales $35.455M Up From $31.815M YoY

  • 05/09/2019

Natural Alternatives Announces Extension to Its Multi-Year Exclusive Manufacturing Agreement with The Juice Plus+ Company

  • 04/05/2019

Natural Alternatives International, Inc. Prevails In Much-Anticipated Federal Circuit Appeal On CarnoSyn Beta-Alanine Patents; Court Holds That CarnoSyn Patents Are 'Patent Eligible'

  • 03/19/2019

Natural Alternatives' CarnoSyn Beta-Alanine Receives New Dietary Ingredient Status From The FDA

  • 02/19/2019

Natural Alternatives Q2 EPS $0.31 Up From $0.29 YoY, Sales $36.04M Up From $33.335M YoY

  • 02/12/2019

Stocks Which Set New 52-Week Low Yesterday, Wed., Nov. 14, 2018

  • 11/15/2018

Natural Alternatives Q1 EPS $0.37 Up From $0.21 YoY, Sales $36.53M Up From $28.074M YoY

  • 11/13/2018

Natural Alternatives Q4 EPS $0.41 Up From $0.23 YoY, Sales $39.2M Up From $32.185M YoY

  • 09/19/2018

Natural Alternatives Q3 EPS $0.30 Up From $0.11 YoY, Sales $25.1M Down From $25.135M YoY

  • 05/14/2018

Natural Alternatives Reports Q2 Adj. EPS $0.29, Sales $33.335M vs $30.559M Est.

  • 02/13/2018

Natural Alternatives Int'l. Late Wed. Night Reported Allowance Of New US Sustained Release Beta-Alanine Patent App

  • 11/30/2017

Natural Alternatives Reports Q1 EPS $0.21 vs $0.37 In Same Qtr. Last Year, Sales $28.074M vs $34.067M

  • 11/13/2017

Natural Alternatives Reports Q4 EPS $0.23 vs $0.52 In Same Qtr. Last Year, Sales $32.185M vs $35.699M YoY

  • 09/18/2017

Natural Alternatives Reports Will Contest Prelim. Beta-Alanine Patent Ruling

  • 09/06/2017

Natural Alternatives Reports Q3 EPS $0.11 vs $0.46 in Same Qtr. Last Year, Sales $25.135M

  • 05/15/2017

Natural Alternatives International, Inc. Reports SR CarnoSyn Receives GRAS Affirmation

  • 04/11/2017

A Micro Stock With Significant Upside Potential

  • 03/09/2017

18 Biggest Mid-Day Losers For Wednesday

  • 02/15/2017

Natural Alternatives International Reports Q2 EPS $0.37 vs. Prior Year Quarter $0.28, Rev. $30.559M vs. Prior Year Quarter $26.91M

  • 02/14/2017

6 Stocks That Plummeted The Past Three Days On Increasing Volume

  • 12/08/2016

Natural Alternatives Reports Q1 EPS $0.37 vs. Prior Year Quarter $0.18, Rev. $34.06M vs. Prior Year Quarter $32.58M

  • 11/07/2016

Worst Performing Industries For October 31, 2016

  • 10/31/2016

Mid-Morning Market Update: Markets Open Higher; Lennar Tops Q3 Expectations

  • 09/20/2016

Natural Alternatives Reports Q4 EPS $0.52, Sales $35.7M

  • 09/19/2016

Top Performing Industries For September 6, 2016

  • 09/06/2016

Benzinga's Volume Movers

  • 05/11/2016

Natural Alternatives Int'l Reports Q3 EPS $0.46 Vs Prior $0.12, Sales $30.006M Vs Prior $19.613M

  • 05/10/2016

Seeking Alpha Pro Article: Large Downside Expected Near-Term For Natural Alternatives International, Inc.

  • 04/29/2016

Natural Alternatives International, Inc. Settles Patent Infringement Claims Against Woodbolt, Grants Woodbolt License To the Beta-Alanine Patents; Other Terms Confidential

  • 03/21/2016

Natural Alternatives Reports Q2 EPS $0.28, Sales $26.9M

  • 02/09/2016

Tiny Titans

  • 01/20/2016

Stocks Hitting 52-Week Highs

  • 12/28/2015

Stocks Hitting 52-Week Highs

  • 11/16/2015

Natural Alternatives int'l Reports Q1 EPS $0.18, Sales $21.6M, no estimates

  • 11/12/2015

Natural Alternatives International Names Michael Fortin CFO

  • 10/01/2015

Natural Alternatives International Reports FY15 EPS $0.49, Rev. $79.5M; Estimates Not Available

  • 09/18/2015

Top Performing Industries For September 4, 2015

  • 09/04/2015

Top Performing Industries For May 18, 2015

  • 05/18/2015

Natural Alternatives Int'l Reports Q3 EPS $0.12, Sales $19.6M, no estimates

  • 05/12/2015

Natural Alternatives Int'l Reports Q4 EPS $0.16, Sales $18.6M, No Estimates Available

  • 02/12/2015

Worst Performing Industries For November 20, 2014

  • 11/20/2014

Natural Alternatives International, Inc. Reports Q3 EPS of $0.07; Revenue of $18.70M

  • 11/12/2014

Morning Market Movers

  • 09/26/2014

Top Performing Industries For September 22, 2014

  • 09/22/2014

Natural Alternatives International, Inc. Reports Q2 EPS of $0.03; Revenue of $16.50M

  • 02/12/2014

Natural Alternatives Internati Reports Q4 EPS $0.11; Revenues $20.9M

  • 09/21/2012

Health Care Sector Wrap

  • 07/05/2012

Natural Alternatives International Announces Issuance of New U.S. Patent Covering CarnoSyn Beta-alanine

  • 03/21/2012

Natural Alternatives International Settles Patent Infringement Dispute With BPI Sports and Image Sports Over its Patented CarnoSyn Beta-Alanine

  • 03/15/2012

Natural Alternatives International Files Patent Infringement Claim Against DNP International Co

  • 02/14/2012

Natural Alternatives International Announces Texas Suit Against Woodbolt Distribution

  • 12/22/2011

Natural Alternatives International Announces Issuance of New U.S. Beta-Alanine Patent Protecting CarnoSyn Products

  • 11/29/2011

Natural Alternatives International Inc. (NAII) CEO Mark A Ledoux buys 1,316 Shares

  • 10/20/2011

Natural Alternatives International, Inc. Announces Resolution of Patent Litigation Case and Renewal of Beta-Alanine Licensing Agreement With Compound Solutions, Inc.

  • 08/12/2011

Natural Alternatives International Announces Stock Repurchase Plan of up to $2M

  • 06/03/2011

Morning Market Losers

  • 06/01/2011
Unlock
NAII Ratings Summary
NAII Quant Ranking